Travere Therapeutics Overview
Travere Therapeutics Target Price
Analysts' 12-month price predictions for TVTX.
Get informed when a big investor buys or sells
+ FollowShare Price
$55.95
Average Target Price
$56.67
1.3% upside
1.3% upside3 analysts in the last 4 months
High: $67 | Low: $49
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-02 | H.C. WainwrightJoseph Pantginis | $67 | 19.7% upside |  |
| 2026-04-14 | Piper Sandler | $49 |  12.4% downside | |
| 2026-04-14 | Guggenheim | $54 | 3.5% downside | |
| 2026-01-14 | GuggenheimVamil Divan | $49 | 12.4% downside | |
| 2025-09-10 | JefferiesMaury Raycroft | $35 | 37.4% downside | |
| 2024-10-31 | Evercore ISILiisa Bayko | $33 | 41% downside | |
| 2024-10-21 | Wells FargoMohit Bansal | $27 | 51.7% downside | |
| 2024-10-10 | Evercore ISILiisa Bayko | $30 | 46.4% downside | |
| 2024-10-09 | Bank of America SecuritiesJason Zemansky | $20 | 64.3% downside | |
| 2024-10-01 | BarclaysCarter Gould | $18 | 67.8% downside | |
| 2024-09-27 | GuggenheimVamil Divan | $23 | 58.9% downside | |
| 2024-09-27 | H.C. WainwrightEd Arce | $18 | 67.8% downside | |
| 2024-09-27 | Bank of America SecuritiesGreg Harrison | $18 | 67.8% downside | |
| 2024-09-10 | Canaccord GenuityEd Nash | $23 | 58.9% downside | |
| 2024-09-09 | GuggenheimVamil Divan | $12.5 | 77.7% downside | |
| 2024-08-28 | Piper SandlerNicole Gabreski | $12 | 78.6% downside | |
| 2024-08-02 | H.C. WainwrightEd Arce | $10 | 82.1% downside | |
| 2024-05-07 | Canaccord GenuityEd Nash | $9 | 83.9% downside | |
| 2024-04-24 | H.C. WainwrightEd Arce | $9.5 | 83% downside | |
| 2022-12-05 | Wells Fargo | $28 | 50% downside | |